EligibleTrials

Liver Adiposity Effects on Pediatric Statin

Recruiting · NCT04903223 · Interventional (participants receive a specific treatment) · Lead sponsor: Children's Mercy Hospital Kansas City

View the official record on ClinicalTrials.gov →
Obesity

Interventions studied

Rosuvastatin 10mg

What this trial is about

Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin

Who can take part

Age range
8 Years to 21 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.